Aston Sci. Alternatives & Competitors

12 companies similar to Aston Sci. — Empowering Patients with Innovative Cancer Immunotherapy

Apexigen

Creating Transformative Immunotherapies for Patients with Cancer

11 Post-IPO Equity $175.80M

San Carlos, United States

Biopharma Biotechnology +2

Adlai Nortye

Pioneering the future of oncology with innovative drug development across the globe.

51-200 Post-IPO Equity $293.00M

Biotechnology Health Care +1

Biond Biologics Ltd

Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics f...

43 Series C $32.00M

Israel

Biotechnology Health Care +1

AVEO Oncology

Committed to delivering medicines that provide a better life for patients with cancer.

197 Post-IPO Equity

Boston, United States

Biotechnology Health Care +2

Track all Aston Sci. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Regor Therapeutics Group

We aspire to be a world class innovative drug discovery company from China.

37 $140.00M

Shanghai, China

Biotechnology Pharmaceutical

MimiVax, Inc.

Disrupting Cancer with Immunotherapy

3 Venture round $16.55M

Buffalo, United States

Biopharma Biotechnology +1

Vidac Pharma

New Paradigm in Cancer Drug Discovery: Dissociating HK2/VDAC and pro-immune Tumor microenv...

8 Series A $9.00M

Ness Ziona, Israel

Biopharma Biotechnology +2

Apollomics

We are a biopharmaceutical company committed to the discovery and development of mono- and...

26 Post-IPO Equity $262.60M

Foster City, United State...

Biotechnology Health Care +1

OncXerna Therapeutics

Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...

8 Venture round $126.50M

Waltham, United States

Biopharma Biotechnology +3

Poolbeg Pharma plc

Focused on the development & commercialisation of innovative medicines. Ticker: POLB

15 Grant

London, United Kingdom

Biotechnology Pharmaceutical

Albert Labs

Innovative mental health medicines for patients with unmet needs

8 Post-IPO Debt $830.00K

London, United Kingdom

Biotechnology Health and Wellness +1

Beihai Biotech

Putting Patients First, Innovation for All

1 Series C $300.00M

Biopharma Biotechnology +1

About Aston Sci.

Aston Sci. is a clinical-stage biopharmaceutical company founded in 2018, headquartered in Korea South. The company's slogan, "Empowering Patients with Innovative Cancer Immunotherapy," aligns with its focus on developing innovative medicines in oncology, immunology, and geriatrics.

Taxonomy

Clinical-stage Biopharmaceutical, Oncology, Immunology, Cancer Immunotherapy, Therapeutic Cancer Vaccines, Proteostasis Modulators, Geriatrics, DNA, MRNA, Peptide, Drug Development, Pharmaceuticals, Innovation

Frequently Asked Questions

Companies similar to Aston Sci. include Apexigen, Adlai Nortye, Biond Biologics Ltd, AVEO Oncology, Regor Therapeutics Group. They work in Biotechnology and Pharmaceutical and share Aston Sci.'s focus on oncology, drug development and cancer immunotherapy.

Bounce Watch lists 12 companies that share Aston Sci.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Aston Sci. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Aston Sci. Profile Apexigen Alternatives Adlai Nortye Alternatives Biond Biologics Ltd Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Aston Sci. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.